Analyst Price Targets — RDNT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 20, 2026 9:15 am | Andrew Mok | Barclays | $65.00 | $53.35 | TheFly | RadNet price target lowered to $65 from $70 at Barclays |
| March 3, 2026 3:56 pm | Brian Tanquilut | Jefferies | $91.00 | $72.01 | StreetInsider | Jefferies Reiterates Buy Rating on RadNet (RDNT); "We remain bullish on RDNT" |
| January 9, 2026 10:35 am | — | UBS | $92.00 | $78.38 | TheFly | RadNet initiated with an Overweight at KeyBanc |
| January 8, 2026 9:14 pm | — | KeyBanc | $92.00 | $78.38 | TheFly | RadNet initiated with an Overweight at KeyBanc |
| December 17, 2025 10:06 am | David MacDonald | Truist Financial | $90.00 | $71.23 | StreetInsider | Truist Securities Reiterates Buy Rating on RadNet (RDNT) |
| November 14, 2025 9:24 am | John Ransom | Raymond James | $95.00 | $73.46 | StreetInsider | RadNet (RDNT) PT Raised to $95 at Raymond James |
| September 3, 2025 1:12 pm | — | Truist Financial | $81.00 | $70.95 | TheFly | RadNet price target raised to $81 from $74 at Truist |
| July 10, 2025 2:00 pm | David MacDonald | Truist Financial | $74.00 | $57.28 | StreetInsider | Truist on RadNet (RDNT): 'Positive EBCD Reimbursement Update From SC' |
| January 22, 2025 1:40 pm | David MacDonald | Truist Financial | $88.00 | $61.77 | TheFly | RadNet price target lowered to $88 from $94 at Truist |
| December 5, 2024 5:10 pm | Brian Tanquilut | Jefferies | $100.00 | $79.16 | StreetInsider | RadNet (RDNT) PT Raised to $100 at Jefferies |
Latest News for RDNT
Bessemer Group Inc. grew its holdings in shares of RadNet, Inc. (NASDAQ: RDNT) by 11.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 550,172 shares of the medical research company's stock after purchasing an additional 56,173 shares during the quarter. Bessemer
RadNet's DeepHealth gains FDA clearances for AI breast imaging tools that assess cardiovascular risk and compare prior mammograms.
SOMERVILLE, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), announces it has received FDA 510(k) clearances for two new Breast Suite1 functionalities: Breast Arterial Calcification (BAC) Assessment, a tool applied to standard screening mammograms that automatically identifies breast arterial…
On June 22, 2026, RadNet Inc (RDNT) shares rose 3.8% today, trading at $55.74. The stock has experienced a 52-week range of $50.76 to $85.84, reflecting volatil
On June 10, 2026, RadNet Inc (RDNT) shares rose 3.5% today, trading at $58.16. The stock has seen a 52-week range between $50.76 and $85.84, indicating signific
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for RDNT.
U.S. House Trading
No House trades found for RDNT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.